ULINICI, M. (2023). Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays. One Health & Risk Management , 77. Retrieved from https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657